Equities

BPH Energy Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BPH:ASX

BPH Energy Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded4.75m
  • 1 Year change+11.11%
  • Beta2.2834
Data delayed at least 20 minutes, as of Feb 06 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BPH Energy Limited is an Australia-based diversified company holding investments in resources and medical technology. The Company holds a significant interest in an unlisted oil and gas exploration company. The Company’s principal activities include investments in various companies, which include Clean Hydrogen Technologies Corporation (Clean Hydrogen Technologies), Cortical Dynamics Limited (Cortical), Advent Energy Limited, and Molecular Discovery Systems Limited (MDSystems). Clean Hydrogen Technologies is a USA Delaware registered company with technology to produce clean hydrogen. The Advent Energy Limited is an unlisted oil and gas exploration and production company based in Perth, Western Australia. The Cortical is a medical device company focused on developing brain function monitors by employing theories and technologies in the field. MDSystems focuses on drug discovery and the validation of biomarkers for disease, therapy and diagnostics.

  • Revenue in AUD (TTM)836.64k
  • Net income in AUD6.79m
  • Incorporated2001
  • Employees2.00k
  • Location
    BPH Energy LtdLevel 1Unit 12/114 Cedric Street, StirlingPERTH 6021AustraliaAUS
  • Phone+61 89328-8366
  • Fax+61 89328-8733
  • Websitehttps://www.bphenergy.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Invion Ltd0.00-8.81m7.11m8.00--0.8538-----0.1183-0.11830.000.09720.00-------70.63-29.16-77.64-30.88-------147.34----0.00---100.00---56.50------
Vectus Biosystems Ltd18.77k-1.78m7.21m--------384.31-0.0334-0.03340.0004-0.00480.0134--0.0266---126.57-79.19-247.24-189.44-----9,468.62-10,165.010.9301-554.06-----75.5873.6123.99------
Percheron Therapeutics Ltd371.10k-14.92m8.70m8.00--0.8696--23.44-0.0149-0.01490.00040.00920.0275--0.2824---110.67-79.28-153.98-96.61-----4,021.00-3,694.96---1,093.500.0026---39.7164.80-25.19---6.74--
Invex Therapeutics Ltd461.52k-476.87k9.39m----1.79--20.35-0.0063-0.00630.00610.06980.0797--4.92---8.23-15.04-8.72-15.74-----103.33-419.12----0.00---72.9222.7470.95------
Biotron Ltd0.00-318.57k9.46m4.00--8.42-----0.0004-0.00040.000.00040.00-------43.23-86.63-206.95-112.69------------0.00------90.73------
Chimeric Therapeutics Ltd3.97m-10.43m11.05m----2.68--2.78-0.0071-0.00710.00290.00090.2154--1.73---56.62-66.67-171.92-112.0278.66---262.83-2,013.07---62.300.7162------16.76------
Nexsen Ltd-100.00bn-100.00bn12.34m--------------------------------------------------47.44---605,140.90------
Adalta Ltd695.66k-4.50m12.75m--------18.33-0.0059-0.00590.0009-0.00050.1804--0.4992---116.72-70.41-216.60-126.24-----647.19-207.18---75.411.51---61.02-28.9716.33------
Imagion Biosystems Ltd1.06m-2.20m12.76m--------12.08-0.0177-0.01770.0082-0.01921.45--1,173.13---302.58-76.63---102.36-----208.52-911.24---0.7972-----18.5422.0283.43------
BPH Energy Ltd836.64k6.79m13.54m2.00k1.760.3152--16.180.00570.00570.00070.03170.0241--10.59--19.549.0519.929.45----811.09431.04----0.0022---0.834428.3448.9343.33----
Cambium Bio Ltd670.05k-3.84m13.55m----5.88--20.22-0.3489-0.34890.05960.10040.1498--2.58---85.96-41.30-146.56-75.4470.04---573.73-118.71----0.2082--419.43-16.63-70.42------
Patrys Ltd828.54k-3.01m18.72m15.00--10.61--22.60-0.0156-0.01560.00430.00330.2808--0.7647---102.13-58.09-143.30-63.36-----363.69-250.93----0.00---40.571.4014.86------
Neurotech International Ltd2.58m-10.60m19.44m----5.33--7.53-0.0103-0.01030.00250.00280.3341--12.69---137.17-130.68-142.71-148.274.41---410.57-428.9311.34--0.00---22.6199.30-109.08------
Noxopharm Ltd2.83m-4.88m19.58m1.00k--28.38--6.92-0.0167-0.01670.00970.00240.4979--1.06---85.95-49.70-156.33-59.16-----172.63-229.01----0.7823--17.54-19.45-36.50------
Data as of Feb 06 2026. Currency figures normalised to BPH Energy Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.